Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4238)
All Articles published online
|
Aug 14, 2009 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724 [PMID: 19673011 DOI: 10.3748/wjg.15.3713] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i30/3713.htm |
| Number | Citing Articles |
| 1 |
Laurie L. Kenney, Markus Cornberg, Alex T. Chen, Sebastien Emonet, Juan Carlos de la Torre, Liisa K. Selin, S. Perlman. Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis. Journal of Virology 2015; 89(21): 10786 doi: 10.1128/JVI.01432-15
|
| 2 |
Marfoua S. AliA , Salema R.M Qowaiderb , Souad A M. Moftah. Seroprevalence rates of transfusion-transmitted infections among blood donors in Northeast of Libya. مجلة العلوم والدراسات الإنسانية - كلية الآداب والعلوم – المرج 2024; (19): 1 doi: 10.37376/1571-000-019-009
|
| 3 |
M. Salavert, R. Granada, A. Díaz, R. Zaragoza. Role of viral infections in immunosuppressed patients. Medicina Intensiva (English Edition) 2011; 35(2): 117 doi: 10.1016/S2173-5727(11)70016-9
|
| 4 |
Antonios Katsounas, Jonathan J. Hubbard, Crystal H. Wang, Xiaozhen Zhang, Diana Dou, Bhavana Shivakumar, Sophie Winter, Joerg F. Schlaak, Richard A. Lempicki, Henry Masur, Michael Polis, Shyam Kottilil, Anu Osinusi. High interferon‐stimulated gene ISG‐15 expression affects HCV treatment outcome in patients co‐infected with HIV and HCV. Journal of Medical Virology 2013; 85(6): 959 doi: 10.1002/jmv.23576
|
| 5 |
Tamás Kálai, Judit Erzsébet Pongrácz, Péter Mátyus. Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine. Chemistry 2022; 4(2): 216 doi: 10.3390/chemistry4020019
|
| 6 |
Madeline Odigie, Anu Osinusi, Lisa Barrett, Kerry Townsend, Honghui Wang, Anthony F. Suffredini, Henry Masur, Michael A. Polis, Shyam Kottilil. Interleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients. AIDS Research and Human Retroviruses 2014; 30(8): 775 doi: 10.1089/aid.2014.0003
|
| 7 |
Pam Kimball, Felecia McDougan, Richard Stirling. CXCR3 Expression Elevated on Peripheral CD8+Lymphocytes from HIV/HCV Coinfected Individuals. Viral Immunology 2011; 24(6): 441 doi: 10.1089/vim.2011.0035
|
| 8 |
M. Salavert, R. Granada, A. Díaz, R. Zaragoza. Papel de las infecciones víricas en pacientes inmunodeprimidos. Medicina Intensiva 2011; 35(2): 117 doi: 10.1016/j.medin.2010.12.003
|
| 9 |
AW Wahid Ansari, Reinhold E Schmidt, Esaki M Shankar, Adeeba Kamarulzaman. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0341-8
|
| 10 |
Maria D. Hernandez, Kenneth E. Sherman. HIV/hepatitis C coinfection natural history and disease progression. Current Opinion in HIV and AIDS 2011; 6(6): 478 doi: 10.1097/COH.0b013e32834bd365
|
| 11 |
Alessandra Sacchi, Chiara Agrati, Gianpiero D'Offizi, Chrysoula Vlassi, Gabriella Rozera, Isabella Abbate, Maria Rosaria Capobianchi, Federico Martini. The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients. Clinical Immunology 2011; 138(2): 178 doi: 10.1016/j.clim.2010.11.001
|
| 12 |
Woori Lee, Daniel K. Cho, Sara D. Ragi, Amor Khachemoune. Skin cancer in patients who are co-infected with HIV/ HBV or HIV/HCV: a systematic review. Archives of Dermatological Research 2024; 317(1) doi: 10.1007/s00403-024-03529-5
|
| 13 |
Satish Balasaheb Nimse, Taisun Kim. Biological applications of functionalized calixarenes. Chem. Soc. Rev. 2013; 42(1): 366 doi: 10.1039/C2CS35233H
|
| 14 |
Sonia de Castro, María-José Camarasa. Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?. European Journal of Medicinal Chemistry 2018; 150: 206 doi: 10.1016/j.ejmech.2018.03.007
|
| 15 |
Shehzad N. Merwat, John M. Vierling. HIV Infection and the Liver: The Importance of HCV-HIV Coinfection and Drug-Induced Liver Injury. Clinics in Liver Disease 2011; 15(1): 131 doi: 10.1016/j.cld.2010.09.012
|
| 16 |
Hans L. Tillmann, John G. McHutchison. Zakim and Boyer's Hepatology. 2012; : 564 doi: 10.1016/B978-1-4377-0881-3.00031-0
|
| 17 |
Jonathan E. Schelfhout, Danijela A. Stojanovic, Amy Houtchens, Heidi M. Crane, Edward R. Cachay, Elizabeth R. Brown, Sonia M. Napravnik, Mari M. Kitahata, Michael S. Saag, Peter W. Hunt, Teresa L. Kauf, Joseph A. C. Delaney. Progression of Platelet Counts in Treatment Naïve HIV/HCV Co-Infection. World Journal of AIDS 2013; 3(01): 36 doi: 10.4236/wja.2013.31006
|
| 18 |
Christine U. Oramasionwu, Heather N. Moore, Joshua C. Toliver. Barriers to Hepatitis C Antiviral Therapy in HIV/HCV Co-Infected Patients in the United States: A Review. AIDS Patient Care and STDs 2014; 28(5): 228 doi: 10.1089/apc.2014.0033
|
| 19 |
Vivian Ng, Sammy Saab. Effects of a Sustained Virologic Response on Outcomes of Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 2011; 9(11): 923 doi: 10.1016/j.cgh.2011.05.028
|
| 20 |
Dimitrios Dimitroulis, Serena Valsami, Eleftherios Spartalis, Emmanuel Pikoulis, Gregory Kouraklis. Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus. World Journal of Hepatology 2013; 5(6): 323-327 doi: 10.4254/wjh.v5.i6.323
|
| 21 |
Reza Zadmard, Nahid S. Alavijeh. Protein surface recognition by calixarenes. RSC Adv. 2014; 4(78): 41529 doi: 10.1039/C4RA05181E
|
| 22 |
J G Rabkin, M C McElhiney, R Rabkin. Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. International Journal of STD & AIDS 2011; 22(2): 95 doi: 10.1258/ijsa.2010.010326
|
| 23 |
S Vernadakis, GC Sotiropoulos, EI Brokalaki, S Esser, GM Kaiser, VR Cicinnati, S Beckebaumi, A Paul, Z Mathé. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. European Journal of Medical Research 2011; 16(8): 342 doi: 10.1186/2047-783X-16-8-342
|
| 24 |
F Ortu, LE Weimer, M Floridia, PE Manconi. Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity. European Journal of Medical Research 2010; 15(2) doi: 10.1186/2047-783X-15-2-81
|
| 25 |
Vidya Vedham, Rao L. Divi, Vaurice L. Starks, Mukesh Verma. Multiple Infections and Cancer: Implications in Epidemiology. Technology in Cancer Research & Treatment 2014; 13(2): 177 doi: 10.7785/tcrt.2012.500366
|
| 26 |
Bing Chen, Bing Xu, Hai‐yan Cui, Zhong‐hui Ma, Wen‐hui Guo, Li‐jian Pei, Wen‐ge Xing. Comparison of effectiveness and cost of different HCV testing strategies in high‐risk populations in China. Journal of Medical Virology 2024; 96(2) doi: 10.1002/jmv.29433
|
| 27 |
Alan Kennedy, Martina Hennessy, Colm Bergin, Fiona Mulcahy, Susan Hopkins, J Paul Spiers. Ribavirin and Interferon Alter Mmp-9 Abundance In Vitro and in HIV–HCV-Coinfected Patients. Antiviral Therapy 2011; 16(8): 1237 doi: 10.3851/IMP1867
|
| 28 |
Sagarika Shahriar, Yusha Araf, Rasel Ahmad, Pravakar Kattel, Ganga Sagar Sah, Tanjim Ishraq Rahaman, Rahila Zannat Sadiea, Shahnaj Sultana, Md. Sayeedul Islam, Chunfu Zheng, Md. Golzar Hossain. Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.780887
|
| 29 |
Lun K. Tsou, Ginger E. Dutschman, Elizabeth A. Gullen, Maria Telpoukhovskaia, Yung-Chi Cheng, Andrew D. Hamilton. Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4]arene scaffold. Bioorganic & Medicinal Chemistry Letters 2010; 20(7): 2137 doi: 10.1016/j.bmcl.2010.02.043
|
| 30 |
Mohamed A. Daw, Amira Shabash, Abdallah El-Bouzedi, Aghnya A. Dau, Jason Blackard. Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya. PLoS ONE 2014; 9(6): e98793 doi: 10.1371/journal.pone.0098793
|
| 31 |
Current World Literature. Current Opinion in Supportive & Palliative Care 2010; 4(3): 207 doi: 10.1097/SPC.0b013e32833e8160
|
| 32 |
Ana Moreno, Carmen Quereda, Jesús Fortún, Rafael Bárcena, María J Pérez-Elías, José L Casado, Miguel A Rodríguez-Sagrado, María L Mateos, Carlos Blesa, Santiago Moreno. Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage. AIDS 2010; 24(8): 1231 doi: 10.1097/QAD.0b013e328336e9b3
|
| 33 |
Aymin Delgado–Borrego. Treating Hepatitis C: Are Children the Same as Adults?. Gastroenterology 2011; 140(2): 389 doi: 10.1053/j.gastro.2010.12.017
|
| 34 |
Kristine A. Scordo. Treating antiretroviral-induced dyslipidemia in HIV-infected adults. The Nurse Practitioner 2010; 35(7): 32 doi: 10.1097/01.NPR.0000383658.60403.6b
|
| 35 |
Glennah Kerubo, Samoel Khamadi, Vincent Okoth, Nyovani Madise, Alex Ezeh, Ziraba Abdalla, Matilu Mwau, Carlo Federico Perno. Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya. PLOS ONE 2015; 10(6): e0129247 doi: 10.1371/journal.pone.0129247
|
| 36 |
Anthony D. Martinez, Robert G. Gish. HCV In At Risk Populations: Who Can be Treated and How?. Current Hepatitis Reports 2012; 11(1): 1 doi: 10.1007/s11901-011-0119-x
|